Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma
Clinical trial NCT03241186 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03241186
- Sponsor
- Robert R. McWilliams, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-12
- Primary completion
- 2022-09-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.